FAQ

Priorix

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1998-2017
012319982017

Related topics

Related topics

1 relation

Broader (1)

Measles-Mumps-Rubella Vaccine

Related mentions per year

Related mentions per year

1946-2018
19401960198020002020
Priorix
Measles-Mumps-Rubella Vaccine

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Risk of febrile convulsions after MMRV vaccination in comparison to MMR or MMR+V vaccination.
BACKGROUND In July 2006, Priorix-Tetra™, a combined measles-mumps-rubella-varicella (MMRV) vaccine, was licensed in Germany… (More)
Is this relevant?
2012
2012
Influence of an immunopotentiator Polyoxidonium on cytokine profile and antibody production in children vaccinated with Priorix.
60 children aged 1-2 years old (32 boys and 28 girls) were vaccinated with Priorix. Vaccinated children included healthy control… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
  • table 3
Is this relevant?
2010
2010
Influenza vaccine concurrently administered with a combination measles, mumps, and rubella vaccine to young children.
Children aged 11 to <24 months received 2 intranasal doses of live attenuated influenza vaccine (LAIV) or placebo, 35+/-7 days… (More)
Is this relevant?
2009
2009
Comparative analysis of the complete nucleotide sequences of measles, mumps, and rubella strain genomes contained in Priorix-Tetra and ProQuad live attenuated combined vaccines.
Measles, mumps, and rubella are three common viral childhood diseases that can have serious complications. Active immunization… (More)
Is this relevant?
2007
2007
Risks of convulsion and aseptic meningitis following measles-mumps-rubella vaccination in the United Kingdom.
Measles-mumps-rubella (MMR) vaccines containing the Urabe strain of mumps were withdrawn in the United Kingdom in 1992 following… (More)
  • table 2
Is this relevant?
2007
2007
Safety and immunogenicity of early vaccination with two doses of tetravalent measles-mumps-rubella-varicella (MMRV) vaccine in healthy children from 9 months of age.
BACKGROUND This open, randomized, controlled study [208136/018] assessed the safety and immunogenicity of early vaccination with… (More)
Is this relevant?
2006
2006
Immediate injection pain in infants aged 18 months during vaccination against measles, mumps and rubella with either Priorix or MMR-II.
The aim of this study was to investigate whether, the vaccine Priorix causes less immediate injection pain than MMR-II in… (More)
Is this relevant?
2002
2002
Concomitant administration of varicella vaccine with combined measles, mumps, and rubella vaccine in healthy children aged 12 to 24 months of age.
The reactogenicity and immunogenicity of three combined measles, mumps and rubella (MMR) vaccines and one administered with a… (More)
Is this relevant?
2000
2000
Reactogenicity and immunogenicity of a new combined measles-mumps-rubella vaccine: results of a multicentre trial. The Cooperative Group for the Study of MMR vaccines.
A large single blind, multi-centre study involving 1779 children was performed in Italy. Infants, aged between 12 and 27 months… (More)
Is this relevant?
1998
1998
Comparative study of reactogenicity and immunogenicity of new and established measles, mumps and rubella vaccines in healthy children.
Concerns about the association of aseptic meningitis with measles-mumps-rubella (MMR) vaccines containing the Urabe Am 9 strain… (More)
Is this relevant?